| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/03/2001 | US6253762 Metered dose inhaler for fluticasone propionate |
| 07/03/2001 | CA2216231C Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/03/2001 | CA2214005C Process and crystal forms of 2-methyl-thieno-benzodiazepine |
| 07/03/2001 | CA2198580C Combination therapy to treat osteoporosis |
| 07/03/2001 | CA2166891C Method for making freeze dried drug dosage forms |
| 07/03/2001 | CA2141704C Concentrated aqueous argatroban solutions |
| 07/03/2001 | CA2101310C Novel arylglycinamide derivatives and preparative processes therefor |
| 07/03/2001 | CA2098108C Water dispersible tablets |
| 07/03/2001 | CA2078773C Gp75 as a tumor vaccine for melanoma |
| 07/03/2001 | CA2077641C Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief |
| 07/03/2001 | CA2023012C 4-substituted 17.beta.-(cyclopropylamino)androst-5-en-3.beta.-ol and related compounds useful as c17-20 lyase inhibitors |
| 07/03/2001 | CA2013516C Preparation process of new thieno-triazolo-diazepine |
| 07/03/2001 | CA2009508C Pf 1022 substance, method of producing same and anthelmintic composition containing same |
| 06/29/2001 | CA2329576A1 Optically active 3-[(2-piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-ht1d receptor selective antagonists |
| 06/29/2001 | CA2328781A1 Novel antibacterial and prokinetic macrolides |
| 06/29/2001 | CA2293913A1 Treatment of necrotizing infections |
| 06/28/2001 | WO2001046699A1 INHIBITION OF βARRESTIN MEDIATED EFFECTS PROLONGS AND POTENTIATES OPIOID RECEPTOR-MEDIATED ANALGESIA |
| 06/28/2001 | WO2001046455A2 Survivin promotion of angiogenesis |
| 06/28/2001 | WO2001046420A2 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
| 06/28/2001 | WO2001046408A2 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 06/28/2001 | WO2001046392A2 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | WO2001046355A1 Stabilisation of pigments and polyunsaturated oils and oil concentrates |
| 06/28/2001 | WO2001046327A2 1,1-disubstituted ethylene adhesive compositions containing polydimethylsiloxane |
| 06/28/2001 | WO2001046263A1 Novel compounds |
| 06/28/2001 | WO2001046255A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | WO2001046212A1 Treatment of viral infections using levovirin?tm¿ |
| 06/28/2001 | WO2001046206A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046205A1 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046204A1 Aromatic phosphonates as protein tyrosine phosphatase 1b (ptp-1b) inhibitors |
| 06/28/2001 | WO2001046203A1 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b) |
| 06/28/2001 | WO2001046200A1 Novel piperidine and piperazine derivatives |
| 06/28/2001 | WO2001046199A1 Methods and compounds for inhibiting mrp1 |
| 06/28/2001 | WO2001046196A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 06/28/2001 | WO2001046195A1 Hydantoin derivative compounds, pharmaceutical compositions, and methods of using same |
| 06/28/2001 | WO2001046192A1 SPIRO COMPOUNDS USEFUL AS OPIOID δ RECEPTOR AGONIST |
| 06/28/2001 | WO2001046191A1 4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives |
| 06/28/2001 | WO2001046189A1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
| 06/28/2001 | WO2001046185A1 Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents |
| 06/28/2001 | WO2001046184A1 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046183A1 SUBSTITUTED 1,3,4-OXADIAZOLES AND A METHOD OF REDUCING TNF-α LEVELS |
| 06/28/2001 | WO2001046180A2 Novel derivatives of 3-imino-1,2-dithioles, method for producing them and pharmaceutical compositions containing the same |
| 06/28/2001 | WO2001046178A2 Substituierte bisindolymaleimide |
| 06/28/2001 | WO2001046176A2 Non peptide tachykinin receptor antagonists |
| 06/28/2001 | WO2001046175A1 Diamidine compounds as dna minor groove binders |
| 06/28/2001 | WO2001046174A1 Novel compounds |
| 06/28/2001 | WO2001046172A1 Pyrazole cyclic amp-specific pde inhibitors |
| 06/28/2001 | WO2001046168A1 Tryptase inhibitors |
| 06/28/2001 | WO2001046167A1 α-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS |
| 06/28/2001 | WO2001046166A2 Partially saturated calcium channel blockers |
| 06/28/2001 | WO2001046164A1 Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials |
| 06/28/2001 | WO2001046158A1 Method for production of a triazolinethione derivative |
| 06/28/2001 | WO2001046157A1 Benzo[a]phenazin-11-carboxamide derivatives and their use as joint inhibitors of topomerase i and ii |
| 06/28/2001 | WO2001046155A1 Potassium channel inhibitors |
| 06/28/2001 | WO2001046151A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 06/28/2001 | WO2001046150A2 Quinolone compounds for use in treating viral infections |
| 06/28/2001 | WO2001046148A1 Novel processes |
| 06/28/2001 | WO2001046146A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046145A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046144A1 New modulators of dopamine neurotransmission |
| 06/28/2001 | WO2001046140A1 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 06/28/2001 | WO2001046138A1 Inhibitors of farnesyl protein transferase |
| 06/28/2001 | WO2001046137A1 Farnesyl transferase inhibitors |
| 06/28/2001 | WO2001046136A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 06/28/2001 | WO2001046134A1 6-KETO PROSTAGLANDIN F1α AND ANALOGS FOR TREATING DRY EYE |
| 06/28/2001 | WO2001046132A1 Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease |
| 06/28/2001 | WO2001046131A1 Method for making 24(s)-hydroxyvitamin d¿2? |
| 06/28/2001 | WO2001046128A2 Tryptase inhibitors |
| 06/28/2001 | WO2001046127A1 Acyl pseudopeptides bearing a functionalised auxiliary spacer |
| 06/28/2001 | WO2001046126A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | WO2001046125A2 Cd45 inhibitors |
| 06/28/2001 | WO2001046115A1 Unsaturated fatty acids and their uses in therapy |
| 06/28/2001 | WO2001046114A1 Method for making hbed |
| 06/28/2001 | WO2001045762A2 Wound healing medical pharmaceutical product |
| 06/28/2001 | WO2001045751A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 06/28/2001 | WO2001045749A1 Cosmid dna constructs and methods of making and using the same |
| 06/28/2001 | WO2001045742A1 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof |
| 06/28/2001 | WO2001045741A2 Methods for preparing pharmaceutical formulations |
| 06/28/2001 | WO2001045740A2 Compositions and methods for treatment of breast cancer |
| 06/28/2001 | WO2001045739A1 Remedies and/or preventives for nervous system disorders |
| 06/28/2001 | WO2001045732A2 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| 06/28/2001 | WO2001045730A2 Tweak receptor |
| 06/28/2001 | WO2001045727A2 Stabilized veterinary compositions comprising more than one antiviral agent |
| 06/28/2001 | WO2001045717A2 Pharmaceutical composition comprising a vanadium compound and at least a component selected from a na+/h+ exchanger, cyclo-oxygenase inhibitors and caspase inhibitors |
| 06/28/2001 | WO2001045716A1 Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and a na+/h+ exchange inhibitor |
| 06/28/2001 | WO2001045715A2 Combinations of an adenosine a1 agonist with an opioid and their use in the treatment of pain |
| 06/28/2001 | WO2001045714A2 Formulations of adenosine a1 agonists |
| 06/28/2001 | WO2001045713A1 Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method |
| 06/28/2001 | WO2001045712A1 Combinations of medicaments for treating viral diseases |
| 06/28/2001 | WO2001045711A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045710A1 Pharmaceutical composition containing [1-{[1-(1,3-benzodioxol-5-ylmethyl)-1h-imidazol-5-yl]methyl}-4-(1-naphthyl)-1h-pyrrol-3-yl](4-methyl-1-piperazinyl)methanone |
| 06/28/2001 | WO2001045709A1 Substituted piperazine and piperidine calcium channel blockers |
| 06/28/2001 | WO2001045708A1 Use of dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants |
| 06/28/2001 | WO2001045707A1 Inhibitors of prenyl-protein transferase |
| 06/28/2001 | WO2001045706A1 Dual-release compositions of a cyclooxygenase-2- inhibitor |
| 06/28/2001 | WO2001045705A1 Sustained-release formulation of a cyclooxygenase-2 inhibitor |
| 06/28/2001 | WO2001045704A1 Inhibitors of prenyl-protein transferase |
| 06/28/2001 | WO2001045703A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 06/28/2001 | WO2001045702A1 SUBSTITUTED ACYLHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS |
| 06/28/2001 | WO2001045701A1 Natural extracted and synthetic antioxidant compositions |
| 06/28/2001 | WO2001045700A1 Urotensin-ii receptor antagonists |